Citigroup Inc Ginkgo Bioworks Holdings, Inc. Transaction History

Citigroup Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$0.28 - $1.16 $167,593 - $694,314	-598,547 Reduced 43.71%	770,816 $254,000
Q1 2024 May 10, 2024	BUY	$1.06 - $1.67 $880,051 - $1.39 Million	830,237 Added 154.0%	1,369,363 $1.59 Million
Q4 2023 Feb 09, 2024	SELL	$1.26 - $1.79 $59,569 - $84,625	-47,277 Reduced 8.06%	539,126 $911,000
Q3 2023 Nov 09, 2023	SELL	$1.61 - $2.54 $285,395 - $450,250	-177,264 Reduced 23.21%	586,403 $1.06 Million
Q2 2023 Aug 10, 2023	SELL	$1.14 - $1.95 $51,375 - $87,878	-45,066 Reduced 5.57%	763,667 $1.42 Million
Q1 2023 May 11, 2023	SELL	$1.2 - $2.19 $39,824 - $72,679	-33,187 Reduced 3.94%	808,733 $1.08 Million
Q4 2022 Feb 09, 2023	BUY	$1.63 - $3.52 $235,313 - $508,161	144,364 Added 20.7%	841,920 $1.42 Million
Q3 2022 Nov 10, 2022	SELL	$0.73 - $3.74 $17,025 - $87,228	-23,323 Reduced 3.24%	697,556 $2.18 Million
Q2 2022 Aug 10, 2022	SELL	$2.2 - $4.2 $968,640 - $1.85 Million	-440,291 Reduced 37.92%	720,879 $1.72 Million
Q1 2022 May 12, 2022	BUY	$2.83 - $8.69 $3.2 Million - $9.83 Million	1,131,654 Added 3834.04%	1,161,170 $4.68 Million
Q4 2021 Feb 10, 2022	BUY	$8.31 - $14.92 $245,277 - $440,378	29,516 New	29,516 $245,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.